Director

George Llado, Sr.

Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.)·Charles River Laboratories International, Inc.

About

G

e

o

r

g

e

L

l

a

d

o

,

S

r

.

i

s

t

h

e

f

o

r

m

e

r

S

e

n

i

o

r

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

C

h

i

e

f

I

n

f

o

r

m

a

t

i

o

n

O

f

f

i

c

e

r

(

C

I

O

)

o

f

A

l

e

x

i

o

n

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

,

I

n

c

.

A

n

i

n

d

u

s

t

r

y

v

e

t

e

r

a

n

w

i

t

h

o

v

e

r

3

0

y

e

a

r

s

o

f

p

h

a

r

m

a

c

e

u

t

i

c

a

l

b

u

s

i

n

e

s

s

,

t

e

c

h

n

o

l

o

g

y

,

a

n

d

c

y

b

e

r

-

s

e

c

u

r

i

t

y

e

x

p

e

r

i

e

n

c

e

,

M

r

.

L

l

a

d

o

,

t

h

r

o

u

g

h

h

i

s

t

i

m

e

a

t

A

l

e

x

i

o

n

,

c

o

n

t

r

i

b

u

t

e

d

t

o

t

h

e

d

e

v

e

l

o

p

m

e

n

t

a

n

d

i

m

p

l

e

m

e

n

t

a

t

i

o

n

o

f

i

n

n

o

v

a

t

i

v

e

t

e

c

h

n

o

l

o

g

y

,

e

n

a

b

l

i

n

g

d

a

t

a

-

d

r

i

v

e

n

i

n

s

i

g

h

t

s

a

c

r

o

s

s

A

l

e

x

i

o

n

'

s

R

&

D

,

C

o

m

m

e

r

c

i

a

l

,

M

a

n

u

f

a

c

t

u

r

i

n

g

O

p

e

r

a

t

i

o

n

s

a

n

d

S

u

p

p

l

y

C

h

a

i

n

f

u

n

c

t

i

o

n

s

.

P

r

i

o

r

t

o

j

o

i

n

i

n

g

A

l

e

x

i

o

n

,

M

r

.

L

l

a

d

o

s

e

r

v

e

d

a

s

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

b

u

s

i

n

e

s

s

l

i

n

e

C

I

O

f

o

r

M

e

r

c

k

a

n

d

C

o

.

,

w

h

e

r

e

h

e

l

e

d

t

h

e

p

l

a

n

n

i

n

g

a

n

d

d

e

v

e

l

o

p

m

e

n

t

o

f

I

T

s

o

l

u

t

i

o

n

s

f

o

r

t

h

e

c

o

m

p

a

n

y

'

s

M

a

n

u

f

a

c

t

u

r

i

n

g

D

i

v

i

s

i

o

n

.

B

e

f

o

r

e

t

h

a

t

,

h

e

w

a

s

M

e

r

c

k

'

s

V

i

c

e

P

r

e

s

i

d

e

n

t

,

I

T

a

n

d

b

u

s

i

n

e

s

s

l

i

n

e

C

I

O

f

o

r

t

h

e

G

l

o

b

a

l

C

o

m

m

e

r

c

i

a

l

O

r

g

a

n

i

z

a

t

i

o

n

a

n

d

v

a

r

i

o

u

s

c

o

r

p

o

r

a

t

e

G

&

A

f

u

n

c

t

i

o

n

s

,

a

n

d

h

e

l

e

d

t

h

e

l

a

r

g

e

-

s

c

a

l

e

m

e

r

g

e

r

i

n

t

e

g

r

a

t

i

o

n

o

f

M

e

r

c

k

a

n

d

S

c

h

e

r

i

n

g

-

P

l

o

u

g

h

a

c

r

o

s

s

t

h

e

I

T

a

n

d

S

h

a

r

e

d

B

u

s

i

n

e

s

s

S

e

r

v

i

c

e

s

o

r

g

a

n

i

z

a

t

i

o

n

s

.

H

e

a

l

s

o

h

e

l

d

s

e

v

e

r

a

l

o

t

h

e

r

p

o

s

i

t

i

o

n

s

o

f

i

n

c

r

e

a

s

i

n

g

r

e

s

p

o

n

s

i

b

i

l

i

t

y

a

t

M

e

r

c

k

,

a

n

d

p

r

e

v

i

o

u

s

l

y

w

o

r

k

e

d

a

t

C

i

t

i

b

a

n

k

,

N

.

A

.

M

r

.

L

l

a

d

o

s

e

r

v

e

s

o

n

t

h

e

T

r

a

c

e

L

i

n

k

I

n

c

.

a

n

d

N

a

t

i

o

n

a

l

C

e

n

t

e

r

f

o

r

W

o

m

e

n

&

I

n

f

o

r

m

a

t

i

o

n

T

e

c

h

n

o

l

o

g

y

(

N

C

W

I

T

)

b

o

a

r

d

s

.

H

e

h

a

s

b

e

e

n

a

d

i

r

e

c

t

o

r

o

f

C

h

a

r

l

e

s

R

i

v

e

r

s

i

n

c

e

O

c

t

o

b

e

r

2

0

2

0

.

H

e

w

a

s

s

e

l

e

c

t

e

d

t

o

t

h

e

B

o

a

r

d

i

n

r

e

c

o

g

n

i

t

i

o

n

o

f

h

i

s

e

x

t

e

n

s

i

v

e

e

x

p

e

r

i

e

n

c

e

a

s

a

s

e

n

i

o

r

e

x

e

c

u

t

i

v

e

a

t

g

l

o

b

a

l

c

o

m

p

a

n

i

e

s

i

n

t

h

e

p

h

a

r

m

a

c

e

u

t

i

c

a

l

i

n

d

u

s

t

r

y

,

a

s

w

e

l

l

a

s

h

i

s

t

e

c

h

n

o

l

o

g

y

a

n

d

c

y

b

e

r

-

s

e

c

u

r

i

t

y

e

x

p

e

r

t

i

s

e

.

Since October 2020
Age 60
Tenure 6 yrs

Also at Charles River Laboratories International, Inc.

JF James C. Foster Chair, President and Chief Executive Officer BG Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) NA Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) SB Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) AC Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) ME Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.)

Roles

Organization Role Dates Details
Charles River Laboratories International, Inc. Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.) October 2020–present Current role
Alexion Pharmaceuticals, Inc. Senior Vice President and Chief Information Officer (CIO) Contributed to the development and implementation of technology enabling data-driven insights across R&D, Commercial, Manufacturing Operations and Supply Chain functions.
Merck and Co. Vice President and business line CIO, Manufacturing Division Led the planning and development of IT solutions for the Manufacturing Division.
Merck and Co. Vice President, IT and business line CIO for the Global Commercial Organization and corporate G&A functions Led the large-scale merger integration of Merck and Schering-Plough across the IT and Shared Business Services organizations.
Citibank, N.A. Earlier career role
Alexion Pharmaceuticals, Inc. Senior Vice President and Chief Information Officer 2015-2020
Merck & Co., Inc. Vice President, IT roles of increasing responsibility 1990-2015

External roles

Organization Role Dates
TraceLink Inc. Board member
National Center for Women & Information Technology (NCWIT) Board member
TraceLink Director

Related

Company Charles River Laboratories International, Inc. Company hub Person James C. Foster Chair, President and Chief Executive Officer Person Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) Person Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) Person Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) Person Abraham Ceesay Director (Chief Executive Officer, Rapport Therapeutics) Person Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) Person Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium) Person Reshema Kemps-Polanco Director (Executive Vice President and Chief Commercial Officer, Novartis US) Person Martin W. Mackay Director (Lead Independent Director; Co-Founder and Non-Executive Chair, Rallybio Corporation) Person Craig B. Thompson Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center) Person Virginia M. Wilson Director (Retired Senior Executive Vice President and Chief Financial Officer, TIAA) Person Michael Knell Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer Deal Charles River Laboratories International Agilux Laboratories 2016 Deal page Deal Charles River Laboratories International Argenta And Biofocus Cro Services Division Of Galapagos 2014 Deal page Deal Charles River Laboratories International Blue Stream Laboratories 2016 Deal page
Source: Charles River Laboratories International, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo